Biology and Management of Unusual Plasma Cell Dyscrasias

ISBN-13: 9781441968470 / Angielski / Twarda / 2016 / 202 str.

Todd M. Zimmerman

Opis

This unique book focuses on the non-myeloma plasma cell dyscrasias. A key resource for this group of diseases, the book features the latest in emerging knowledge and therapeutic developments, including novel therapies. Each disease-specific chapter discusses biology, disease course, and appropriate therapeutic interventions, covering plasma cell leukemia, plasmacytoma, POEMS Syndrome and Castleman's Disease, Waldenstrom macroglobulinemia, immunoglobin deposition disease, and cryoglobulinemic syndromes, among others. The only book dedicated to this intriguing family of diseases, Biology and Management of Unusual Plasma Cell Dyscrasias will be a long-lasting reference for clinicians and scientists alike."

Spis treści

Plasma cell leukemia.- PLASMACYTOMA – CURRENT APPROACH TO DIAGNOSIS AND MANAGEMENT.- POEMS Syndrome and Castleman’s Disease.- Waldenström macroglobulinemia.- Light Chain Amyloidosis.- Immunoglobulin Deposition Disease.- Cryoglobulinemic Syndromes: Diagnosis and Management.- Idiopathic Systemic Capillary Leak Syndrome (Clarkson Disease).- Renal Disease Associated with Monoclonal Gammopathy.

O autorze

Todd M. Zimmerman, MD

Section of Hematology/Oncology

The University of Chicago

Chicago, IL, USA

 

Shaji Kumar, MD

Division of Hematology

Mayo Clinic

Rochester, MN, USA

Blurb

This unique book focuses on the non-myeloma plasma cell dyscrasias. A key resource for this group of diseases, the book features the latest in emerging knowledge and therapeutic developments, including novel therapies. Each disease-specific chapter discusses biology, disease course, and appropriate therapeutic interventions, covering plasma cell leukemia, plasmacytoma, POEMS Syndrome and Castleman's Disease, Waldenström macroglobulinemia, immunoglobin deposition disease, and cryoglobulinemic syndromes, among others. The only book dedicated to this intriguing family of diseases, Biology and Management of Unusual Plasma Cell Dyscrasias will be a long-lasting reference for clinicians and scientists alike.